Most pharma AI initiatives don’t fail because the technology is weak. They fail because the operating model can’t support scale. AI pilots succeed, early wins create momentum — and then everything stalls the moment content, compliance, and localization hit real workflows.

This internal brief cuts through the hype and gets to the structural reality: AI only scales where a content system already exists to support it. Inside, we outline what the highest-performing pharma teams do differently — and the five failure patterns that quietly kill momentum before results can land.

‍
What you'll learn:

• The five most common reasons pharma AI initiatives stall after the pilot stage
• What a scalable content system looks like — and why most teams don't have one yet
• How top teams redesign governance to enable speed, not slow it down
• The difference between AI bolted onto workflows vs. embedded inside them
• Five diagnostic questions to pressure-test your organisation's AI readiness